TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.

Discussions tagged IVAC

IVAC VIMS Report on Global Vaccine Introduction - January 2015 (Now with IPV)

The January 2015 edition of the IVAC VIMS Report on Global Vaccine Introduction is now available at http://www.jhsph.edu/research/centers-and-institutes/ivac/vims/IVAC-VIMS-Report-2015-Jan.pdf

New in the January edition is the addition of an inactivated polio vaccine (IPV) section in the report....

IVAC VIMS Report on Global Vaccine Introduction - September 2014

The IVAC VIMS Report on Global Vaccine Introduction - September 2014 is out!

Recent updates (since March 2014) include:

-South Sudan's introduction of Haemophilus influenzae type b (Hib) vaccine in July 2014 marks a significant milestone in global health, as Hib-containing pentavalent vaccine is now available in all 73 Gavi countries. To read IVAC...

Vacancy: Advocacy & communications officer, International Vaccine Access Center (IVAC)

About IVAC
The mission of the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health is to accelerate global access to life-saving vaccines through the development and implementation of evidence-based policies. IVAC contributes across the vaccine value chain, focusing on the generation and interpretation of evidence and translation into policies, vaccine introduction, implementation, and optimization. Our value lies in the combination of content kn...

IVAC VIMS Report on Global Vaccine Introduction - December 2013

IVAC-VIMS-Dec-2013-Report.pdf

This report provides data and figures on the introduction status of Haemophilus influenzae type b (Hib), pneumococcal, and rotavirus vaccines both globally and in 73 GAVI-eligible countries using information stored in the Vaccine Information Management System (VIMS) online database, managed by the Internat...

International Vaccine Access Center (IVAC) Meeting 2012

IVAC held a 2-day roundtable meeting with about 40 experts and observers in Washington, DC on May 9th and 10th to review the available evidence and develop a framework for improving decision-making related to vaccine vial size, and understand the economics of vaccine choice.

Here is a list of presentation summaries and documents:

Primary Container Considerations for Prequalification
Andrew Meek, World Health Organization [
  • Page :
  • 1